Lessee, Operating Lease, Liability, to be Paid, Year Two of Emergent BioSolutions Inc. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Emergent BioSolutions Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Dec 2021 to 31 Dec 2025.
Emergent BioSolutions Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Dec 2025 was $3,100,000, a 11% increase year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Emergent BioSolutions Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$3,100,000	+$300,000	+11%	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q4 2024	$2,800,000	-$900,000	-24%	31 Dec 2024	10-K	04 Mar 2025	2024	FY
Q4 2023	$3,700,000	-$600,000	-14%	31 Dec 2023	10-K	08 Mar 2024	2023	FY
Q4 2022	$4,300,000	-$2,600,000	-38%	31 Dec 2022	10-K/A	11 Dec 2023	2022	FY
Q4 2021	$6,900,000			31 Dec 2021	10-K	25 Feb 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.